Ilhan, O. Et Al. 2019. Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Ilhan, O., CENGİZ SEVAL, G., TOPRAK, S. K., CİVRİZ BOZDAĞ, S., YÜKSEL, M., Topcuoglu, P., ... Arslan, O.(2019). Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients? . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Ilhan, Osman Et Al. "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2019

Ilhan, Osman Et Al. "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2019

Ilhan, O. Et Al. (2019) . "Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Osman Ilhan Et Al. }, title={Can autologous stem cell transplantation abrogate the poor prognosis associated with high LDH in myeloma patients?}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2019}}